Article written by Bruce Sylvester. Treatment with two anti-nausea medications appears to alleviate headaches which took patients to the emergency room in the weeks after the initial injury…. read more.
A novel psychological therapy that encourages addressing emotional experiences related to trauma, conflict and relationship problems has been found helpful for people with the chronic pain condition fibromyalgia.
Article written by Christine Clark Storage of drug products at ultra-low temperatures calls for understanding of the special risks involved…
Article written by Gary Finnegan. The European Medicines Agency (EMA) has given the green light for ten new medicines at the latest meeting of its influential Committee for… read more.
In a study by Rebecca Rothwell and colleagues, which appears in Arthritis & Rheumatology, possible considerations of non-inferiority (NI) trials assessing treatment effects in RA are discussed.
Article written by Bruce Sylvester Dozens of the most widely used blood pressure medications show no tendency to elevate risk of depression, Danish researchers report.
Written by Bruce Sylvester Researchers report that there is no link between statin use and cognitive decline. The findings were published on Nov. 18, 2019 in the Journal… read more.
The use of tyrosine kinase inhibitors (TKIs) in the treatment of ALK-positive NSCLC is now well-established. Professor Ross Camidge (University of Colorado Cancer Centre, Denver, USA) described the lessons that… read more.
Correvio Pharma has resubmitted a New Drug Application (NDA) to the US FDA seeking approval for Brinavess (vernakalant hydrochloride, IV), its antiarrhythmic drug for the rapid conversion of adult patients with recent onset atrial fibrillation (AF).
Dr Fiona McDonald (London, UK) discusses radical treatment for oligo metastatic NSCLC and if it should be the standard of care and Professor James Spicer (London, UK), the session Chair, gives… read more.
Professor Kwee Yong (London, UK) details the results from the Tourmaline-MM3 study
Dr Johan Burisch (Denmark) reviews data he presented on the cost saving effect of biological therapy in patients with IBD.